This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chan, A. W. Articles by Ellis, S. G. Search for Related Content PubMed PubMed Citation Articles by Chan, A. W. Articles by Ellis, S. G.

Mortality benefit of beta-blockade after successful elective percutaneous coronary intervention

^* Section of Interventional Cardiology, Department of Cardiovascular Medicine, The Cleveland Clinic Foundation, Cleveland, Ohio, USA

View larger version (15K): [in a new window]   Figure 1 Kaplan-Meier estimation of the survival rates within the first year after percutaneous coronary intervention (PCI).

View larger version (15K): [in a new window]   Figure 2 Independent predictors for mortality at one year after percutaneous coronary intervention. CAD = coronary artery disease; CI = confidence interval; COPD = chronic obstructive pulmonary disease; LVEF = left ventricular ejection fraction.

View larger version (42K): [in a new window]   Figure 3 Subgroup comparisons of the one-year survival rates among patients who were treated with beta-adrenergic blocking agents with those who were not treated with beta-blockers at the time of percutaneous coronary intervention (PCI). ACC/AHA = American College of Cardiology/American Heart Association; CABG = coronary artery bypass grafting; CAD = coronary artery disease; CHF = congestive heart failure; CI = confidence interval; COPD = chronic obstructive pulmonary disease; LVEF = left ventricular ejection fraction; MI = myocardial infarction; NYHA = New York Heart Association; SVG = saphenous vein graft.